Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
16,34 USD | -1,15 % |
|
-3,71 % | +7,01 % |
Resumen de negocios
Número de empleados: 1 000
Ventas por actividad
GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Buprenorphine-based Prescription Drugs
100,0
%
| 731 | 100,0 % | 879 | 100,0 % | +20,21 % |
Ventas por región
GBP en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
83,4
%
| 593 | 81,1 % | 734 | 83,4 % | +23,63 % |
Rest of World
16,1
%
| 133 | 18,2 % | 142 | 16,1 % | +6,34 % |
United Kingdom
0,5
%
| 5 | 0,7 % | 4 | 0,5 % | -17,42 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Crossley
CEO | Chief Executive Officer | - | 01/01/12 |
Ryan Preblick
DFI | Director of Finance/CFO | - | 01/01/12 |
Cynthia Cetani
CMP | Compliance Officer | - | 01/10/18 |
Chief Tech/Sci/R&D Officer | - | 01/12/14 | |
Kathryn Hudson
IRO | Public Communications Contact | 50 | 15/07/15 |
Jason Thompson
IRC | Investor Relations Contact | - | - |
Vishal Kalia
PRN | Corporate Officer/Principal | - | - |
Hillel West
PRN | Corporate Officer/Principal | - | - |
Jon Fogle
HRO | Human Resources Officer | - | 01/10/14 |
Richard Simkin
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 65 | 01/11/19 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 01/06/22 |
Mark Stejbach
BRD | Director/Board Member | 61 | 24/03/21 |
Jerome Lande
BRD | Director/Board Member | 48 | 24/03/21 |
Peter Bains
BRD | Director/Board Member | 65 | 01/08/19 |
Mark Crossley
CEO | Chief Executive Officer | - | 01/01/12 |
Juliet Thompson
BRD | Director/Board Member | 57 | 24/03/21 |
Director/Board Member | 60 | 24/03/21 | |
Ryan Preblick
DFI | Director of Finance/CFO | - | 01/01/12 |
Keith Humphreys
BRD | Director/Board Member | - | 09/11 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 134 293 798 | 129 848 775 ( 96,69 %) | 0 | 96,69 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
AELIS FARMA 5.29% | 701 469 | 5.29% | 10 051 995 $ |
Información de la empresa
Indivior PLC
10710 Midlothian Turnpike Suite 125
23235, North Chesterfield
+804 379 1090
http://indivior.com![Dirección Indivior PLC(INDV)](https://cdn.zonebourse.com/static/address/120795799.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
RBP Global Holdings Ltd.
![]() RBP Global Holdings Ltd. Financial ConglomeratesFinance Part of Indivior PLC, RBP Global Holdings Ltd. is a British investment company. The company is based in Slough, UK. RBP Global Holdings was founded in 2013. |
Financial Conglomerates
|
Sector
Ventas por región
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+14,66 % | 9247,6 M | |
+42,52 % | 4447,35 M | |
-22,31 % | 4430,94 M | |
+10,76 % | 4029,41 M | |
-27,16 % | 2181,92 M | |
+11,24 % | 2020,35 M | |
-43,24 % | 1790,73 M | |
-0,50 % | 1644,13 M | |
-10,19 % | 1428,78 M |
- Bolsa de valores
- Acciones
- Acción INDV
- Acción INDV
- Empresa Indivior PLC